Table 6.
Univariate analysis for progression free survival by log-rank test
| Variable | Number | Progression-free survival (months) | P value |
|---|---|---|---|
| Primary tumor site |
|
|
|
| Extrahepatic bile duct |
18 |
4.6 |
0.2551 |
| Gallbladder |
10 |
3.4 |
|
| Recurrence or unresectable |
|
|
|
| Recurrence |
22 |
3.9 |
0.7073 |
| Unresectable |
6 |
7.4 |
|
| Histological type |
|
|
|
| Well/moderately |
21 |
4.4 |
0.7255 |
| Poor |
7 |
5.2 |
|
| hENT1 expression |
|
|
|
| Low |
11 |
2.5 |
0.0065 |
| High |
17 |
7.7 |
|
| dCK expression |
|
|
|
| Low |
13 |
4.6 |
0.8076 |
| High |
15 |
3.7 |
|
| RRM1 expression |
|
|
|
| Low |
11 |
7.4 |
0.1349 |
| High | 17 | 2.5 |
dCK, deoxycytidine kinase; hENT1, human equilibrative nucleoside transporter; RRM1, ribonucleotide reductase subunit M1.